Artificial Intelligence Molecular Screen (AIMS) program is designed to dramatically accelerate the race towards life-saving drugs by analyzing millions of compounds for each disease led by Atomwise. Proposals from university scientists are assessed and ranked and the top 3 teams in each round will receive 72 potential medicines for free. We are very much looking forward to screening this set of compounds!! Stay tuned for progress.
https://www.atomwise.com/aims-awards/
